Extended levobunolol release from Eudragit nanoparticle-laden contact lenses for glaucoma therapy
Abstract Background Majorly, the reason for the permanent loss of vision is glaucoma. But the currently available common treatment methodologies such as eye drops have various disadvantages like patient incompliance due to repeated administration and poor (1-5%) bioavailability leading to poor effic...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
SpringerOpen,
2020-11-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|